Navigation Links
US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
Date:8/25/2008

HOUSTON, Aug. 25 /PRNewswire/ -- US Oncology, Inc. today announced the appointment of Stephen Smith as Vice President/General Manager Research and Personalized Science Services. Smith will oversee the US Oncology Research Network, which provides research management services to oncology practices and sites throughout the nationwide US Oncology Network.

The research network allows physicians to accelerate the availability and use of scientific, evidence-based medicine and share best practices. It has played a pivotal role in 24 of the last 30 cancer drugs approved by the FDA and more than 32,000 patients have participated in clinical trials.

Smith joins US Oncology from INC Research, Inc. where he was Senior Vice President, Global Oncology. Prior to INC Research, he worked as CFO of Clinical Pharmacology and Labs for Pharmaceutical Product Development, Inc., a multinational healthcare technology and services firm. Smith served as an officer in the United States Army for five years.

Smith earned a Bachelor of Science degree from the United States Military Academy, a Master of Science degree from the University of Northern Colorado and a Master of Business Administration degree from Syracuse University, Whitman School of Management.

"We are excited to have Stephen as part of our team," said Bruce Broussard, president and chief executive officer of US Oncology. "Our research network is a strategic part of our mission to increase patient access to high-quality cancer care. With Stephen's background and expertise we will further our goal of enhancing patient access to the latest investigational therapies."

"I am proud to be a part of US Oncology. Its continued commitment to such a comprehensive research network and to advancing oncology research in novel ways are important drivers of the innovative services US Oncology supports in all phases of the cancer care delivery system," said Smith.

Smith is based at the company's headquarters in Houston, Texas.

About US Oncology, Inc.

US Oncology, headquartered in Houston, works closely with physicians, manufacturers and payers to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology's expertise in supporting every aspect of the cancer care delivery system -- from drug development to treatment and outcomes measurement, enables the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,247 physicians operating in 472 locations, including 91 radiation oncology facilities in 39 states. For more information, visit the company's Web site, http://www.usoncology.com.


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
2. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
3. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
4. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
5. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
6. PRA International to Present Audioconference on Oncology Research - Nov. 8
7. IMPAC Medical Systems to Offer Revenue Cycle Inc.s Array of Oncology Products and Services to Customers
8. AG Mednet to Provide Image Network for Southwest Oncology Group
9. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
10. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
11. Oncology Metrics and Cureline Announce Joint Marketing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... and scientists from around the world, is pleased to announce the 2nd annual ... 23, 2017. This premier, online-only conference focused on the development and advancements in ...
(Date:2/22/2017)... Dublin - Research and Markets has announced ... Type, By Application, By End User, By Region, By Country: Opportunities ... ... is forecasted to grow at a CAGR of 11.33% during 2016-2021. ... protection market is driven by the surging demand for less toxic ...
(Date:2/22/2017)... 2017 Aethlon Medical, Inc. (Nasdaq: ... that validated the ability of the Aethlon HemopurifierĀ® to ... mortality in immune-suppressed sepsis patients and also contribute to ... objective of the study was to validate the ... (EBV) and Herpes Simplex virus 1 (HSV1) by the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pharma and biotech consulting firm ... director. Operating from Pennsideā€™s Zurich headquarters, Pennside Partners, GmbH, Mr. Perkins brings 14 ... more than a decade with leading market research firm, GfK. He began his ...
Breaking Biology Technology:
(Date:2/9/2017)... , Feb. 9, 2017 The biomass boiler ... of the biomass boiler market globally in terms of ... biomass boilers. The market for biomass boilers has been ... end-user, application, and country/region. The market based on feedstock ... forest residues, biogas & energy crops, urban residues, and ...
(Date:2/8/2017)... The biometrics market has reached a ... organizations, desires to better authenticate or identify users ... challenge questions), biometrics is quickly working its way ... is driven by use cases, though there traditionally ... uses cases, with consumer-facing use cases encompassing authentication, ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
Breaking Biology News(10 mins):